Veloxis Pharmaceuticals to Present Data Differentiating LCP-Tacro(TM) from ... MarketWatch (press release) HORSHOLM, Denmark, Oct. 10, 2012 /PRNewswire via COMTEX/ -- Veloxis will give two upcoming data presentations that further define the profile of LCP-Tacro compared to other tacrolimus formulations. The first study demonstrates the potentially flexible ... |
